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tropic support (p<0.01).
Conclusion: HFABP is a rapid marker for assessment of myocardial damage and clinical
outcome in pediatric cardiac surgery. In particular, serum HFABP levels immediately after
an aortic declamping may be a potentially useful prognostic indicator of myocardial dam-
age as well as clinical outcome in pediatric cardiac surgery. 
1039-205 Partial Anomalous Pulmonary Venous Connection: 
Warden Versus Non-Warden in a Contemporaneous 
Surgical Cohort
Camille L. Hancock Friesen, Andrea Schnell, Kimberlee Gauvreau, Pedro J. del Nido, 
Joseph M. Forbess, Richard A. Jonas, John E. Mayer, Jr., J. Keane, Michael F. Flanagan, 
Emile Bacha, Children's Hospital Boston, Boston, MA
Background: The Warden procedure for repair of right-sided partial anomalous pulmo-
nary venous connection (PAPVC) comprises dividing the SVC above the anomalous pul-
monary veins, over sewing the proximal SVC stump, anastomosis of the distal SVC to the
right atrial appendage and baffling of the pulmonary veins to the interatrial communica-
tion. We reviewed our operative series to compare the incidence systemic venous
obstruction, pulmonary venous obstruction and sinus node dysfunction (as indicated by
12 lead EKG at most recent follow up) in patients with right-sided PAPVC undergoing the
Warden procedure (W) versus a traditional baffle operation (B).
Methods: We reviewed all available data for 92 pts with right-sided PAPVC who were
operatively repaired in a single institution 01/88-12/00. The W technique was used when
one of the anomalous RPV entered the SVC cephalad to the SVC-RA junction such that
using a standard B repair would entail a long and potentially obstructing baffle.
Results: Thirty-eight pts were repaired using the W procedure, 54 had traditional B oper-
ations (39 had isolated baffle, 15 had baffle plus SVC-RA junction augmentation). Eigh-
teen pts had additional procedures. Males comprised 68.4% of the W and 46.3% of B
pts, p=0.06. Both pt cohorts were similar in age (W median 4y vs B 3y, p=0.06) and
weight at surgery (W median 14.3 kg vs B 15 kg, p=0.09). The total pump and cross
clamp times were similar between the groups. There were no early or late mortalities. W
pts had a shorter median length of stay in hospital (4 d vs 5 d, p=0.008). There was a
higher incidence of asymptomatic SVC obstruction in W pts compared with B pts (18.4%
vs 3.7%, p=0.03) with a trend to increased reintervention (2/3 were symptomatic) in the
W cohort (7.9% vs 0, p=0.07). Reintervention in 2 pts was single balloon dilation and 1 pt
required reoperation. Pulmonary vein obstruction occurred in 1/38 W vs 5/66 B pts,
p=0.4, with one pt in each group requiring reintervention. Non sinus rhythm was rare (W
1/38, B 0/54) with no patients requiring a pacemaker although the study is underpowered
to detect a difference.
Conclusions: The W procedure is associated with a higher risk of asymptomatic SVC
obstruction than the B approach.
1039-206 Determinants of Intensive Care Unit Length of Stay for 
Infants Undergoing Cardiac Surgery
Matthew J. Gillespie, Marijn Kuijpers, Maaike Van Rossem, Sarah Tabbutt, J. William 
Gaynor, Thomas L. Spray, Bernard J. Clark, III, The Children's Hospital of Philadelphia, 
Philadelphia, PA
Background: To better understand the determinants of medical cost in infants undergo-
ing cardiac surgery we determined factors that influence postoperative intensive care unit
length of stay (ICLOS).
Methods: Records of infants < 6 months of age at time of surgery from 1/2000-12/2000
were reviewed. Diagnostic and surgical severity were adjusted using the Aristotle Basic
Complexity Score (ABCS; range 1-4).
Results: Of 223 infants, 68 had elective surgery, ie admission to the CICU after surgery
and 155 had non-elective surgery with admission to the CICU preoperatively. Elective vs
non-elective groups differed: ABCS(median 2 vs 3, p<0.001), age at surgery (mean 110
+10.5 vs 27+3.7days, p<0.001), Total LOS (median 5 vs 10 days, p<0.001) ICLOS
(median 3 vs 5.5 days, p<0.002) and mortality (1.5% vs 14.5% p<.0001). Step wise mul-
tiple regression was performed using the natural log of ICLOS as the dependent variable
(R2 range .66-.76). Factors associated with longer ICLOS included: higher ABCS, total
hours of ventilatory support, total support time (TST = bypass + circulatory arrest times),
postop cardiac catheterization, postop necrotizing enterocolitis and postop NG feeds.
Higher preop weight and surgical repair vs palliation decreased ICLOS.
Conclusion: Operative and postop factors influenced ICLOS more than factors related to
preop clinical condition. The ABCS provided an efficient method of severity adjustment
for diagnosis and surgical procedures. The ABCS was significantly correlated with
ICLOS.
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1057-199 Characteristics and Outcomes of Fetuses With 
Pericardial Effusions
Timothy C. Slesnick, Nancy A. Ayres, Carolyn A. Altman, Louis I. Bezold, Benjamin W. 
Eidem, J. Kennard Fraley, Grace C. Kung, John P. Kovalchin, Baylor College of Medicine, 
Houston, TX
BACKGROUND: Limited information is known about the characteristics and outcomes of
fetuses with pericardial effusions (PCE). We sought to identify factors associated with
fetal PCE, the natural history, and outcomes of fetuses with PCE.
METHODS: We reviewed our fetal echocardiography database from 1993 to 2002, and
all pts with PCE were included in the study. Size of PCE, presence of structural heart dis-
ease, hydrops, cardiac function, arrhythmias, and extracardiac malformations were deter-
mined for each pt. Pts were divided into small (<4 mm) and large (>4 mm) PCE groups
for comparison. Follow-up and outcome data were evaluated, and comparisons were
made between survivors and nonsurvivors.
RESULTS: PCE were present in 104 fetuses (mean gestational age 28.6 ± 5.0 weeks),
including 80 small and 24 large PCE. Forty-seven pts had structural heart disease, 37
hydrops, 29 impaired cardiac function, 26 arrhythmias, and 14 extracardiac malforma-
tions. Twenty pts had PCE without any other fetal abnormalities (isolated), including 19
small and 1 large PCE. Large PCE were associated with a higher likelihood of structural
heart disease (p=0.03) and impaired function (p=0.01), but not with hydrops, arrhythmias
or extracardiac malformations. Repeat fetal echos were performed in 52 pts, with resolu-
tion of PCE in 25 pts (48%), 23 small and 2 large. Postnatal echos were performed in 45
pts, with resolution of PCE in 41 pts (91%), 30 small and 11 large. Only 4 of these pts
had postnatal PCE, all of whom had large fetal PCE. Outcome data were available for 83
pts (80%), with 26 total deaths. PCE with hydrops (p=0.05) or extracardiac malformations
(p=0.001) were associated with death. However, PCE size, structural heart disease, car-
diac function, and arrhythmias were not associated with death. Isolated PCE was associ-
ated with survival (p=0.03).
CONCLUSIONS: Large PCE in fetuses are associated with structural heart disease and
impaired cardiac function, though large PCE are not associated with death. Additionally,
fetuses with PCE in the presence of hydrops or extracardiac malformations have a high
risk of mortality. The majority of fetal PCE resolve, and fetuses with isolated PCE have a
very good prognosis.
1057-200 Maternal Hyperglycemia Acutely Improves Fetal Cardiac 
Function During Tachycardia-Induced Heart Failure
Michael R. Schmidt, Morten Smerup, Steen Kristiansen, Paul White, Keld Sorensen, 
Andrew Redington, Vibeke Hjortdal, Aarhus University Hospital, Skejby, Aarhus, 
Denmark, Hospital for Sick Children, Toronto, Canada
Introduction: Sustained fetal tachycardia may lead to cardiac failure, hydrops, and
intrauterine death. We have previously shown that glucose-insulin infusion improves fetal
cardiac function during tachycardia. Maternal hyperglycemia induces fetal hyperinsuline-
mia and may be a therapeutic strategy.
Hypothesis: We hypothesized that cardiac function during fetal tachycardia can be
improved by induced maternal hyperglycemia.
Methods: 7 control fetuses and 5 hyperglycemia (HG) fetuses (all 7-10 days preterm)
from 6 pregnant sows were studied. LV pressure was measured using a 1.4F high fidelity
pressure catheter positioned in the LV via the left carotid artery. Systolic function was
measured as dP/dtmax. Fetal pacing was established with a1F pace catheter placed in
the RV through the left internal jugular vein. Fetuses were paced at 300 ± 30 bpm for 3
hours. During investigation of control fetuses, sows received saline infusion. In HG
fetuses, maternal 20% glucose infusion was initiated after 1 hour and maternal blood glu-
cose clamped at 15±1 mmol/l.
Results: Figure. dP/dtmaxdeclined during the first 60 min. In the control group, dP/dtmax
continued declining to 815±302 mmHg/s at 120 min and 660±299 mmHg/s at 180 min. In
contrast, systolic function improved after maternal hyperglycemia was induced in the HG
Variable Coefficient t value p value
postop cath 0.996 5.983 0.000
Mech vent time 0.001 5.575 0.000
total support time 0.003 2.702 0.008
Complexity Score 0.111 1.939 0.05
preop weight -0.082 -2.472 0.014
postop NG feeds 0.369 3.969 0.000
postop NEC 0.826 4.07 0.000
surgical repair -0.171 -2.033 0.043
380A ABSTRACTS - Pediatric Cardiology and Adult Congenital Heart Disease JACC March 3, 2004
Pe
di
at
ric
 C
ar
di
ol
og
y 
an
d 
Ad
ul
t C
on
ge
ni
ta
l H
ea
rt
 D
is
ea
se
group; dP/dtmax was 999±253 mmHg/s at 120 min (p=0.016) and 854±209 mmHg/s at
180 min (p=0.054).
Conclusion: Induced maternal hyperglycemia improves fetal cardiac function during
fetal tachycardia. 
1057-201 Fetal Aortic Stenosis With Apex-Forming Left Ventricle 
at Time of Diagnosis: Determinants of Biventricular 
Repair
Masaki Nii, Rajiv Chaturvedi, Kevin Roman, Edgar T. Jaeggi, The Hospital for Sick 
Children, Toronto, Canada
Background: Aortic stenosis (AS) may result in impaired and preserved growth of the
left heart. Potential for biventricular repair is critical in counseling and management.
Objectives: To assess the value of markers in predicting suitability for biventricular (BV)
versus single ventricular (SV) repair in fetal AS.
Methods: Review of all cases of fetal AS, diagnosed at our center since 1995. Inclusion
criteria were 1) apex-forming left ventricle (LV) at time of diagnosis, 2) intact ventricular
septum, and 3) serial follow-up studies to birth. The following parameters were assessed
at diagnosis: Ventricular dimensions and systolic functions, orientation of aortic and
foraminal flows, and presence/absence of endocardial fibroelastosis. Analysis of the pul-
monary venous flow to assess diastolic function included peak velocity of reversed flow
during atrial systole (PVA), integrated time velocity ratio of early diastolic to ventricular
systolic forward flow (D/S), and the ratio of reversed to forward pulmonary venous flow
(A/(S+D)). Depending on the type of postnatal intervention, 2 patient groups were cre-
ated and the parameters compared.
Results. The baseline characteristics of 16 fetuses included in the study are shown. 
Conclusion: In AS with apex-forming LV at time of diagnosis functional indices (LV 
shortening; pulmonary vein flow) provide useful information in predicting left ventricular 
growth potential and suitability for biventricular repair.
1057-202 Changing Indications for Fetal Echocardiography in a 
University Center Population
Mark K. Friedberg, Norman H. Silverman, Stanford University, Stanford, CA
Background
Technical advances and obstetrical education have greatly increased the use of Fetal
Echocardiography (FE) over the past 10 years. Earlier studies showed that the major
indications for FE included a family history of congenital heart disease (CHD), maternal
diabetes and arrythmia. We hypothesized that the increased utilization of FE is associ-
ated with a change in indications and yield of FE.
Methods
We reviewed 300 consecutive FE performed at Stanford University between 12/2002 and
8/2003. Major anomaly was defined as that affecting prognosis.
Chromosomal anomaly was defined either as suspected (based on ultrasound (US) find-
ings) or proven (chromosomal analysis).
Results
Indications for FE and their yield are presented in the table. 
Mean maternal age was 31±6 (range 16-44) years. Of 7 cases with increased nuchal 
thickening, 1 (14%), showed PA/IVS. No cardiac anomalies were found in the presence of 
an abnormal umbilical cord.
Conclusions
Indications for FE have changed over the last 10 years. An obstetrical US suspicious for 
CHD has become a prominent indication for FE, indicating an increased awareness of 
cardiac anomalies by obstetricians. This indication, together with chromosomal 
anomalies, accounts for a large percentage of positive FE. Thus, the yield of FE depends 
to a large extent on the skills of the obstetrician. Common indications that continue to 
have relatively low yield include maternal diabetes, arrhythmia and especially a family 
history of CHD and exposure to a teratogen.
1057-203 Ventricular Function in Fetal Congestive Heart Failure 
and Predictors of Perinatal Outcome
Masaki Nii, Mary van der Velde, Edward N. Marcus, Wendy Tsang, Lisa K. Hornberger, 
The Hospital for Sick Children, Toronto, ON, Canada, Children's Hospital, Boston, MA
Background: Although the types of primary cardiac lesions associated with fetal con-
gestive heart failure (CHF) are well recognized, there is a paucity of data which defines
the associated abnormalities of ventricular function and predictors of outcome. We
sought to determine the specific abnormalities of ventricular function and to identify ven-
tricular functional parameters that may assist in predicting outcome in a large cohort of
affected fetuses. Methods: We reviewed the initial fetal echocardiograms (mean age
25.2±5.2 weeks) and clinical histories of 87 fetuses with CHF due to structural heart dis-
ease (n=41), primary dysrhythmias (n=22) or primary myocardial disease (n=24). LV and
RV shortening fraction (SF), and Tei indices were assessed where possible and com-
pared to previously published normal data. Diastolic dysfunction was considered to be
present when 1 or more of the following indices were abnormal: A/E ratio, deceleration
time, LV-IVRT, IVC, DV and UV flow pattern. In continued pregnancies with known out-
come, parameters were compared between those with fetal or neonatal demise (n=38)
versus survivors (n=26). Results: In the 87 cases of CHF, LV and RV SF were abnormal
in 49.4% and 64.9%, respectively and significantly decreased compared to normal
(LV=27.4±11.7, RV=23.8±11.8,p<0.05). LV and RV Tei-indices were abnormal in 53.1%
and 58.8%, respectively and overall were significantly increased (LV=0.64±0.42, p<0.01;
RV=0.65±0.45, p<0.01). RV SF was significantly lower than the LV (p=0.02) but the RV
and LV Tei-indices were not different. A/E ratio of both ventricles did not differ significantly
from normal (LV=1.31±0.48, RV=1.46±0.62), and RV and LV A/E ratios were not differ-
ent. Diastolic dysfunction was present in 39 of 50 cases with CHF assessed. Of all the
functional parameters compared, only LV SF was significantly decreased in fetuses with
fetal or neonatal demise versus survivors (28.4±10.5 vs 21.5±12.3, respectively, p=0.03).
Conclusion: In fetuses with CHF, RV and LV systolic dysfunction is present in 50-60%
and diastolic dysfunction in 78%. While RV systolic dysfunction is more common in CHF,
the presence of LV systolic dysfunction may further contribute to outcome.
1057-204 Outcome Following Prenatal Identification of Structural 
Heart Disease: A Seven-Year Experience
Geoffrey A. Forbus, Andrew M. Atz, Scott M. Bradley, Girish S. Shirali, Medical University 
of South Carolina, Charleston, SC
Background: This study evaluates outcome in a series of consecutive patients who were
diagnosed prenatally with structural heart defects (SHD) and identifies factors associated
with mortality in this cohort.
Methods: Fetal echo reports at a single institution from August 1995 through November
2002 were reviewed. The following outcomes for fetuses with SHD were evaluated: fami-
lies opting for no active management, hospital survival following surgery at initial admis-
sion, and survival at most recent follow up. Variables evaluated for potential association
with these outcomes included cardiac diagnosis, gestational age at diagnosis and at
birth, gender, birth weight, extracardiac and/or chromosomal anomalies, ethnicity, insur-
ance status (a marker of socioeconomic status), surgery at initial admission, and univen-
tricular versus biventricular management pathway. Univariate and multivariate analysis
were performed.
Results: We identified 168 fetuses with SHD, of whom 126 (75%) chose active treatment.
SV Repair
(n = 8)
BV Repair
(n = 8)
P-Values
Age at diagnosis 21.4+4.3 weeks 21.8+ 5.7 weeks NS
Increase in LV diameter 5/8 (63%) 4/8 (50%) NS
Endocardial fibroelastosis 7/8 (88%) 4/8 (50%) NS
LV shortening fraction 4.0±8.1 % 18.2±17.8 % 0.04
Retrograde aortic flow 3/8 (38%) 0/8 (0%) NS
Left-right atrial shunting 8/8 (100%) 5/8 (63%) NS
PVA reversal 35.4±9.8 cm/s 10.1±0.5 cm/s 0.0001
D/S TVI 0.3±0.3 1.1±0.5 0.007
A/(S+D) TVI 0.52±0.24 0.09±0.07 0.003
Indication No. of 
FE
% of 
FE
No. of Major 
anomalies
No. of Minor 
anomalies
Yield
(%)
Family history of CHD* 68 23 1 2 4
Maternal diabetes 55 18 2 2 7
Abnormal obstetrical US
(Suspicious for CHD)
46 15 15 1 35
Arrythmia 35 12 2 3 14
Extracardiac congenital 
anomalies
29 9 3 0 10
SLE/ +SSA/SSB 21 7 1 2 14
Chromosomal anomaly 18 6 5 4 50
Teratogen Exposure 14 5 0 0 0
Other 9 3 4 1 5
Advanced maternal age 4 1 0 0 0
Not ascertained 1 0.3 0 0 0
Total 300 99.3 33 15 16
